Why the study?
Does the Minnesota Cognitive Acuity Screen (MCAS) predict functional impairment in individuals with mild cognitive impairment or dementia?
Does the Minnesota Cognitive Acuity Screen (MCAS) predict functional impairment in individuals with mild cognitive impairment or dementia?
The MCAS is a brief telephone-based tool that can effectively predict daily functional status in patients with cognitive impairment.
MCAS may aid remote functional screening in cognitive impairment; hypothesis-generating and requires prospective validation.
Despite their growing use, few studies have examined the associations between patients' performance on brief telephone-based cognitive assessments and their functional status. The purpose of this study was to examine the relationship between the Minnesota Cognitive Acuity Screen (MCAS), a very brief telephone-based dementia screening instrument, and functional impairment as rated by the Clinical Dementia Rating (CDR) scale in a sample of 176 individuals diagnosed with mild cognitive impairment or dementia. Results showed lower MCAS scores were correlated with poorer daily function as measured by CDR global scores and domain scores, and the MCAS orientation subscale was one of the strongest subscales in predicting functional status as it was uniquely predictive of all CDR domains. Findings suggest the MCAS appears to be useful in predicting patients' level of daily function and may be useful for quickly and easily monitoring patients' cognitive and functional status over time.
No takes yet. Share an insight, caveat, or question.
Springate et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: